These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 5495481)
21. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel. Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600 [TBL] [Abstract][Full Text] [Related]
22. Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system. Dai W; Zhang D; Duan C; Jia L; Wang Y; Feng F; Zhang Q J Microencapsul; 2010 May; 27(3):234-41. PubMed ID: 20113167 [TBL] [Abstract][Full Text] [Related]
23. Enhancing dissolution of domperidone by spray-drying: effect of different storage conditions on stability. Lee JH; Kim MJ; Yang J; Kim KH; Kim HM; Lee SJ; Lee D; Khang G Ther Deliv; 2014 Mar; 5(3):265-75. PubMed ID: 24592953 [TBL] [Abstract][Full Text] [Related]
24. In vitro dissolution profile and in vivo absorption study of sustained-release tablets containing chlorpheniramine maleate with water-insoluble glucan. Masumoto K; Matsumoto K; Yoshida A; Hayashi S; Nambu N; Nagai T Chem Pharm Bull (Tokyo); 1984 Sep; 32(9):3720-3. PubMed ID: 6525661 [No Abstract] [Full Text] [Related]
25. Preparation, physicochemical characterization and drug release studies of albendazole solid dispersions. Mallick S; Sahoo A; Mitra SS Boll Chim Farm; 2003 May; 142(4):180-6. PubMed ID: 12918228 [TBL] [Abstract][Full Text] [Related]
26. Sustained-release and swelling characteristics of xanthan gum/ethylcellulose-based injection moulded matrix tablets: in vitro and in vivo evaluation. Quinten T; De Beer T; Onofre FO; Mendez-Montealvo G; Wang YJ; Remon JP; Vervaet C J Pharm Sci; 2011 Jul; 100(7):2858-70. PubMed ID: 21254067 [TBL] [Abstract][Full Text] [Related]
27. Perspectives on Strategies Using Swellable Polymers in Solid Dispersions for Controlled Drug Release. Tran TTD; Tran PHL Curr Pharm Des; 2017; 23(11):1639-1648. PubMed ID: 27774901 [TBL] [Abstract][Full Text] [Related]
28. Release of chlorpheniramine maleate from fatty acid ester matrix disks prepared by melt-extrusion. Prapaitrakul W; Sprockel OL; Shivanand P J Pharm Pharmacol; 1991 Jun; 43(6):377-81. PubMed ID: 1681047 [TBL] [Abstract][Full Text] [Related]
29. Super-cooled and amorphous lipid-based colloidal dispersions for the delivery of phytosterols. Ribeiro HS; Gupta R; Smith KW; van Malssen KF; Popp AK; Velikov KP Soft Matter; 2016 Jul; 12(27):5835-46. PubMed ID: 27174457 [TBL] [Abstract][Full Text] [Related]
30. Microencapsulation of drugs with aqueous colloidal polymer dispersions. Bodmeier R; Wang J J Pharm Sci; 1993 Feb; 82(2):191-4. PubMed ID: 8445534 [TBL] [Abstract][Full Text] [Related]
31. Synthesis of poly(sebacic anhydride)-indomethacin controlled release composites via supercritical carbon dioxide assisted impregnation. Gong K; Rehman IU; Darr JA Int J Pharm; 2007 Jun; 338(1-2):191-7. PubMed ID: 17398049 [TBL] [Abstract][Full Text] [Related]
32. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs. Baghel S; Cathcart H; O'Reilly NJ J Pharm Sci; 2016 Sep; 105(9):2527-2544. PubMed ID: 26886314 [TBL] [Abstract][Full Text] [Related]
33. [Sensitivity of cationic polymer Eudragit RL to electrolytes and its effect on drug release from Eudragit RL matrix]. Fu C; Zhao L; Jiang X Yao Xue Xue Bao; 1998 Jul; 33(7):538-43. PubMed ID: 12016889 [TBL] [Abstract][Full Text] [Related]
34. Physical properties and in vivo bioavailability in human volunteers of isradipine using controlled release matrix tablet containing self-emulsifying solid dispersion. Tran PH; Tran TT; Piao ZZ; Vo TV; Park JB; Lim J; Oh KT; Rhee YS; Lee BJ Int J Pharm; 2013 Jun; 450(1-2):79-86. PubMed ID: 23612354 [TBL] [Abstract][Full Text] [Related]
35. Bioavailability of regular and controlled-release chlorpheniramine products. Kotzan JA; Vallner JJ; Stewart JT; Brown WJ; Viswanathan CT; Needham TE; Dighe SV; Malinowski R J Pharm Sci; 1982 Aug; 71(8):919-23. PubMed ID: 7120098 [TBL] [Abstract][Full Text] [Related]
36. Characterization and stability of solid dispersions based on PEG/polymer blends. Bley H; Fussnegger B; Bodmeier R Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875 [TBL] [Abstract][Full Text] [Related]
37. Release characteristics of polyurethane tablets containing dicarboxylic acids as release modifiers - a case study with diprophylline. Claeys B; De Bruyn S; Hansen L; De Beer T; Remon JP; Vervaet C Int J Pharm; 2014 Dec; 477(1-2):244-50. PubMed ID: 25445517 [TBL] [Abstract][Full Text] [Related]
38. Theoretical analysis of factors affecting the formation and stability of multilayered colloidal dispersions. McClements DJ Langmuir; 2005 Oct; 21(21):9777-85. PubMed ID: 16207066 [TBL] [Abstract][Full Text] [Related]
39. Mucoadhesive controlled release microcapsules of indomethacin: optimization and stability study. Ibrahim HM; Ahmed TA; Lila AE; Samy AM; Kaseem AA; Nutan MT J Microencapsul; 2010; 27(5):377-86. PubMed ID: 20690789 [TBL] [Abstract][Full Text] [Related]
40. Chronopharmacokinetic Evaluation of Budesonide Multiparticulate Systems. Battu S; Yalavarthi PR; Gopireddy VSR; Vattikuti UMR; Devi J; Vadlamudi HC Recent Pat Drug Deliv Formul; 2017; 11(3):221-229. PubMed ID: 29237390 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]